Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|January 1, 1996
TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breastM Chitemerere, T I Andersen, R Holm, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1995
Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer populationK Heimdal, T I Andersen, M Skrede, et al.
British Journal of Cancer|September 1, 1993
Prognostic significance of TP53 alterations in breast carcinomaT I Andersen, R Holm, J M Nesland, et al.
Pharmacogenetics|March 25, 1998
A rare CYP19 (aromatase) variant may increase the risk of breast cancerV N Kristensen, T I Andersen, A Lindblom, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 24, 2001
Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphismA Jugessur, P Frost, T I Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosisL Ottestad, T I Andersen, J M Nesland, et al.
Genes, Chromosomes & Cancer|March 1, 1992
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomasT I Andersen, A Gaustad, L Ottestad, et al.
Pageof 5